Manash Baruah

ORCID: 0000-0003-3064-2605
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes Management and Education
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Diet and metabolism studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Metabolism, Diabetes, and Cancer
  • Adrenal Hormones and Disorders
  • Obesity and Health Practices
  • Ethnobotanical and Medicinal Plants Studies
  • Thyroid Disorders and Treatments
  • Adrenal and Paraganglionic Tumors
  • Chronic Disease Management Strategies
  • Pituitary Gland Disorders and Treatments
  • COVID-19 Clinical Research Studies
  • Neuroendocrine Tumor Research Advances
  • Dietary Effects on Health
  • Adipokines, Inflammation, and Metabolic Diseases
  • Natural Antidiabetic Agents Studies
  • Gestational Diabetes Research and Management
  • Clinical Laboratory Practices and Quality Control
  • Plant Diversity and Evolution
  • Health Promotion and Cardiovascular Prevention

CARE Hospitals
2016-2025

Apollo Hospitals
2024

Gauhati University
2020-2022

Excel Life Sciences (India)
2018

Bharti Hospital
2011-2017

All India Institute of Medical Sciences Bhopal
2012

Ibrahim Cardiac Hospital & Research Institute
2012

Bangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders
2012

Shifa International Hospital
2012

Shaukat Khanum Memorial Cancer Hospital and Research Center
2012

Thyroid nodules are common. cancer is rarer. No guidelines exist for management of thyroid in the Indian context and these recommendations intended this purpose. The consensus committee reviewed important articles, including previously published statements. Management points were scored according to level evidence. These cover clinical evaluation include interpretation imaging fine needle aspiration cytology nodules. also special situations like incidentalomas, cystic lesion detected during...

10.4103/2230-8210.77566 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2011-01-01

Abstract: Diabetes and obesity are both increasing at a fast pace giving rise to new epidemic called diabesity. Lifestyle interventions including diet play major role in the treatment of diabetes, There many guidelines on dietary management diabetes or globally also from South Asia. However, there no global Asian non-pharmacological Asia differs rest world as Asians have different phenotype, cooking practices, food resources exposure, medical nutrition therapy (MNT) availability trained...

10.2147/dmso.s278928 article EN cc-by-nc Diabetes Metabolic Syndrome and Obesity 2021-04-01

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are a class of medications that have shown significant efficacy in regulating blood glucose levels and providing additional benefits, such as cardiorenal protection. This study aims to analyze the factors leading nonadherence discontinuation SGLT2i treatment identify strategies can enhance patient compliance reduce withdrawal rates. consensus involved an expert committee comprising 14 opinion leaders, chosen for their profound expertise...

10.59556/japi.73.0887 article EN PubMed 2025-04-01

Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor is effective in reducing HbA1c levels patients with type 2 diabetes (T2DM) when administered as monotherapy, dual or triple combination therapy. In India, Vildagliptin commonly prescribed T2DM because it reduces mean amplitude of glycemic excursion (MAGE), has lower risk hypoglycemia and weight neutral. Early therapy vildagliptin metformin well-tolerated T2DM, regardless age ethnicity. view already existing data on the latest emerging...

10.1177/11795514231203911 article EN cc-by-nc Clinical Medicine Insights Endocrinology and Diabetes 2024-01-01

This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It limitations of existing and analogues, highlights need for newer molecule. The discusses advantages while reviewing its pharmacologic clinical studies done so far. assesses role degludec plus in diabetes practice.

10.4103/2230-8210.83056 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2011-01-01

In the month of Ramadan, patients with thyroid diseases, most time, do not need treatment adjustments and can fast safely without any health hazards. Patients hypothyroidism taking thyroxine take their tablets on an empty stomach at bedtime instead half hour before Sehr. hyperthyroidism, methimazole/carbimazole continue dose in once or twice daily regimes, while those propylthiouracil to be switched. Hyperthyroid severe symptoms should start immediately avoid for few days after a...

10.4103/2230-8210.98001 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2012-01-01

10.4103/0973-0354.110573 article EN Thyroid Research and Practice 2013-01-01

10.4103/0973-0354.129561 article EN Thyroid Research and Practice 2014-01-01

Abstract The second diabetes attitudes wishes and needs 2 (DAWN 2) study describes various facts of living with diabetes, including barriers to, facilitators effective psychosocial care. One the issues studied by DAWN2 is phenomenon discrimination, as viewed persons family members health care professionals. This brief communication discusses high prevalence discrimination against people reported DAWN2.

10.4103/2321-0656.140896 article EN cc-by-nc-nd Journal of Social Health and Diabetes 2014-11-01
Coming Soon ...